GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) » Definitions » Construction In Progress

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Construction In Progress : ¥553 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Anhui Fengyuan Pharmaceutical Co Construction In Progress?

Anhui Fengyuan Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (¥519 Mil) to Dec. 2023 (¥524 Mil) and increased from Dec. 2023 (¥524 Mil) to Mar. 2024 (¥553 Mil).

Anhui Fengyuan Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (¥458 Mil) to Dec. 2022 (¥439 Mil) but then increased from Dec. 2022 (¥439 Mil) to Dec. 2023 (¥524 Mil).

Anhui Fengyuan Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Anhui Fengyuan Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Fengyuan Pharmaceutical Co Construction In Progress Chart

Anhui Fengyuan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.76 368.90 458.25 439.38 524.13

Anhui Fengyuan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 458.41 491.05 518.67 524.13 552.86

Anhui Fengyuan Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) » Definitions » Construction In Progress
Comparable Companies
SZSE:300254 SHSE:688117 SHSE:688373 SHSE:600594 SZSE:301331 SHSE:600222 SZSE:002412 SHSE:688073 SZSE:300436 SHSE:603538 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 108, Beimenwai Street, Wuwei County, Anhui Province, Hefei, CHN, 230051
Website
http://www.bbcayy.com
Anhui Fengyuan Pharmaceutical Co Ltd operates in pharmaceutical research and development, production, and sales. The business of the company includes preparations, API, health care, and commercial logistics. The company is engaged in development of bio innovative drugs and in set up of drug distribution branches.
Executives
Li Guo Kun Executives

Anhui Fengyuan Pharmaceutical Co (SZSE:000153) Headlines

No Headlines